An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the onset of action of fluticasone propionate nasal
spray compared to placebo nasal spray in reducing nasal allergic signs and symptoms following
ragweed exposure in the Allergen BioCube (ABC) after up to 14 days of at home dosing.